Latest News Feed

Press Release Dec 30, 2025
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
Press Release Dec 16, 2025
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
Press Release Mar 12, 2025
CTT Pharma's CEO Issues Letter to Shareholders
Press Release Mar 10, 2025
CTT Pharma Uplists to the OTCQB Today
Press Release Mar 5, 2025
CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading
Press Release Mar 3, 2025
CTT Pharma Gives Uplisting Update
Press Release Feb 25, 2025
CTT Pharma Gives Update On U.S. and European Patents
Press Release Feb 12, 2025
CTT Pharma Gives Update On NSF Grant
Press Release Feb 5, 2025
CTT Pharma Adds Independent Director With NIH/NSF Experience
Press Release Feb 3, 2025
CTT Pharma Reduces Authorized Share Count
Press Release Jan 30, 2025
CTT Pharma Submits Proposal for NIH Grant
Press Release Jan 28, 2025
Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation
Press Release Jun 15, 2021
CTT Pharmaceuticals Existing Canadian Patent Confirmed to Include Psychedelic Applications